Hansa Biopharma — Oktober 2022
-
Hansa Biopharma - Q3 Update fra SEB https://proinvestor.com/boards/106667
-
@B.Andersen - tak!
-
Hansa Biopharma - Oversigt over analytikere og kursmål https://www.proinvestor.com/boards/106987
-
Tisdagen den 18 oktober 2022 kl. 12:59. STOCKHOLM (Nyhetsbyrån Direkt) Hansa Biopharma har fått ett negativt besked gällande ett godkännande av imlifidase i Norge. Det rapporterar norska Dagens Medisin.
-
Hansa Biopharma Interim report January-September 2022
· Total Revenue of SEK 67m in the third quarter 2022
· Positive reimbursement decisions received in Poland and Scotland
· $70 million raised in non-dilutive financing
· Imlifidase included in ESOT guidelines published in Transplant International -
-
Upcoming milestones and news flow
2022 Anti-GBM: Initiation of phase 3 study
2022 NiceR: Completion of GLP tox studies
H2 2022 AMR Phase 2 study: First data read out
H2 2022 U.S. Kidney transplantation: Complete enrollment
H2 2022/H1 2023 GBS Phase 2 study: Complete enrollment
H1 2023 U.S. Kidney transplantation: Complete randomization
H2 2023 GBS Phase 2 study: First data read out
2023 Long-term follow-up data 5-years out in kidney transplantation
2024 Kidney transplantation US: BLA s
-
Jaa, det er da i hvert fald en del højere end hvad jeg havde turde håbe på. Signifikant stigning i R&D, men det må man simpelthen ikke være bange for når man investerer i biotek. Jeg ser intet negativt i dette regnskab. For at snakke om noget andet, den manglende godkendelse i Norge. Er der nogen der ved yderligere? Det virker umiddelbart mystisk at Norge skulle gå mod alle andre i Europa?
-
Hansa Biopharma: Klaus Sindahl, Head of Investor Relations presenterar på Redeye Investor AW – Göteborg 20 oktober 2022:
(Redeye)
-
Op ?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind